{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:14:36Z","timestamp":1781795676897,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-024-01193-4","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:10:38Z","timestamp":1736331038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET"],"prefix":"10.1186","volume":"15","author":[{"given":"Yong-Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Kee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0777-6226","authenticated-orcid":false,"given":"Young-Sil","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322:1589\u201399. https:\/\/doi.org\/10.1001\/jama.2019.4782.","journal-title":"JAMA"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00259-022-05999-z","volume":"50","author":"J Wang","year":"2023","unstructured":"Wang J, Jin C, Zhou J, Zhou R, Tian M, Lee HJ, et al. PET molecular imaging for pathophysiological visualization in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2023;50:765\u201383. https:\/\/doi.org\/10.1007\/s00259-022-05999-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvado G, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49:3508\u201328. https:\/\/doi.org\/10.1007\/s00259-022-05784-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-023-00994-3","volume":"13","author":"HG Pemberton","year":"2023","unstructured":"Pemberton HG, Buckley C, Battle M, Bollack A, Patel V, Tomova P, et al. Software compatibility analysis for quantitative measures of [(18)F]flutemetamol amyloid PET burden in mild cognitive impairment. EJNMMI Res. 2023;13:48. https:\/\/doi.org\/10.1186\/s13550-023-00994-3.","journal-title":"EJNMMI Res"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12149-022-01769-x","volume":"36","author":"E Imabayashi","year":"2022","unstructured":"Imabayashi E, Tamamura N, Yamaguchi Y, Kamitaka Y, Sakata M, Ishii K. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer\u2019s disease. Ann Nucl Med. 2022;36:865\u201375. https:\/\/doi.org\/10.1007\/s12149-022-01769-x.","journal-title":"Ann Nucl Med"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21037\/qims-21-188","volume":"12","author":"EG Muller","year":"2022","unstructured":"Muller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME. Evaluation of semi-quantitative measures of (18)F-flutemetamol PET for the clinical diagnosis of Alzheimer\u2019s disease. Quant Imaging Med Surg. 2022;12:493\u2013509. https:\/\/doi.org\/10.21037\/qims-21-188.","journal-title":"Quant Imaging Med Surg"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","volume":"38","author":"CJ Buckley","year":"2017","unstructured":"Buckley CJ, Sherwin PF, Smith AP, Wolber J, Weick SM, Brooks DJ. Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol beta-amyloid PET brain images. Nucl Med Commun. 2017;38:234\u201341. https:\/\/doi.org\/10.1097\/MNM.0000000000000633.","journal-title":"Nucl Med Commun"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2967\/jnumed.112.115006","volume":"54","author":"R Lundqvist","year":"2013","unstructured":"Lundqvist R, Lilja J, Thomas BA, Lotjonen J, Villemagne VL, Rowe CC, et al. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. J Nucl Med. 2013;54:1472\u20138. https:\/\/doi.org\/10.2967\/jnumed.112.115006.","journal-title":"J Nucl Med"},{"key":"1193_CR9","doi-asserted-by":"publisher","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3.","DOI":"10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11065-009-9118-x","volume":"19","author":"KM Rodrigue","year":"2009","unstructured":"Rodrigue KM, Kennedy KM, Park DC. Beta-amyloid deposition and the aging brain. Neuropsychol Rev. 2009;19:436\u201350. https:\/\/doi.org\/10.1007\/s11065-009-9118-x.","journal-title":"Neuropsychol Rev"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","volume":"78","author":"KM Rodrigue","year":"2012","unstructured":"Rodrigue KM, Kennedy KM, Devous MD, Sr., Rieck JR, Hebrank AC, Diaz-Arrastia R, et al. beta-amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012;78:387\u201395. https:\/\/doi.org\/10.1212\/WNL.0b013e318245d295.","journal-title":"Neurology"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1212\/WNL.0000000000004425","volume":"89","author":"L Mosconi","year":"2017","unstructured":"Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, et al. Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. Neurology. 2017;89:1382\u201390. https:\/\/doi.org\/10.1212\/WNL.0000000000004425.","journal-title":"Neurology"},{"key":"1193_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","volume":"136","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging. Acta Neuropathol. 2018;136:887\u2013900. https:\/\/doi.org\/10.1007\/s00401-018-1920-1.","journal-title":"Acta Neuropathol"},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","volume":"76","author":"RF Buckley","year":"2019","unstructured":"Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, et al. Sex differences in the Association of Global Amyloid and Regional Tau Deposition measured by Positron Emission Tomography in clinically normal older adults. JAMA Neurol. 2019;76:542\u201351. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4693.","journal-title":"JAMA Neurol"},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-020-05174-2","volume":"48","author":"LE Collij","year":"2021","unstructured":"Collij LE, Salvado G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [(18)F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021;48:2169\u201382. https:\/\/doi.org\/10.1007\/s00259-020-05174-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1038\/s41598-023-36986-5","volume":"13","author":"HW Roh","year":"2023","unstructured":"Roh HW, Son SJ, Hong CH, Moon SY, Lee SM, Seo SW, et al. Comparison of automated quantification of amyloid deposition between PMOD and Heuron. Sci Rep. 2023;13:9891. https:\/\/doi.org\/10.1038\/s41598-023-36986-5.","journal-title":"Sci Rep"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-024-01193-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:08:49Z","timestamp":1736334529000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-024-01193-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1186\/s13550-024-01193-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5328496\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Ajou University approved the clinical methodology of this retrospective study (approval code: AJOUIRB-DB-2024-435).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}